Orally Administered Factor Xa Inhibitor, Rivaroxaban
Ricardo J. Komotar+2 more
openalex +1 more source
Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation
D. McCarty, A. Robinson
semanticscholar +1 more source
A new Factor Xa inhibitor from Amblyomma cajennense with a unique domain composition
Isabel de Fátima Correia Batista+5 more
openalex +1 more source
42 Incremental Economic Burden Associated With Major Bleeding among Atrial Fibrillation Patients Treated With Factor Xa Inhibitors [PDF]
Steve Deitelzweig+4 more
openalex +1 more source
The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis. [PDF]
Siegal DM+7 more
europepmc +1 more source
Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. [PDF]
Escobar C+9 more
europepmc +1 more source
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor [PDF]
Nina Haagenrud Schultz+5 more
openalex +1 more source
P1660Effects of factor Xa inhibitors rivaroxaban and apixaban on platelet function [PDF]
Giulia Renda+5 more
openalex +1 more source
Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re‐appraisal
W. H. Dzik
semanticscholar +1 more source